Maynard Um
-
-
-
-
-
-
-
BMO Capital Starts NewAmsterdam Pharma Co NV (NAMS) at Outperform
-
-
-
-
-
-
-
NewAmsterdam Pharma Co NV (NAMS) PT Raised to $45 at Guggenheim
-
-
-
-
-
-
-
NewAmsterdam Pharma (NAMS) spreader of November 22.50 and 30 puts
-
-
-
-
-
-
-
Citi Starts NewAmsterdam Pharma Co NV (NAMS) at Buy
-
-
-
-
-
-
-
NewAmsterdam Pharma (NAMS) Announces Late-Breaking Data from BROADWAY and TANDEM Pivotal Studies Published in Leading Medical Journals, Presented
-
-
-
-
-
-
-
NewAmsterdam Pharma Co NV (NAMS) PT Raised to $47 at Scotiabank
-
-
-
-
-
-
-
Piper Sandler Reiterates Overweight Rating on NewAmsterdam Pharma Co NV (NAMS)
-
466,308 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


